Michael Hallek

This inventor holds 25 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 4 EPO patents, primarily in Adeno-Associated Virus. Top assignees: Medigene Ag, Ludwig-Maximilians-Universitaet, Universitaet Zu Koeln. Active years: 2001-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Hallek. Retrieved from https://idiyas.com/inventor/michael-hallek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 (Patent Applications = 2)

% Patents Active = 56.0

CIPO Patents = 2

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 3.2

ph-index = 11

Forward Citations = 476(Granted Patents)

Location History:

Schondorf, DE (2001 - 2008)
Munich, DE (2001 - 2009)
Cologne, DE (2009 - 2020)

Company Filing History:

Ludwig-Maximilians-Universitaet

patents

3 out of 16

Universitaet Zu Koeln

The University of Texas System

Gsf-Forschungszentrum Für Umwelt Gesundheit, Gmbh

patent

8. 1 out of 1

Gsf-International Research Institute for Environment and Health

patent

9. 1 out of 1

Gsf—forschungszentrum Fur Umwelt Und Gesundheit Gmbh

patent

where one patent can have more than one assignee

Years Active: 2001-2020

Loading Chart...

Areas of Expertise:

Adeno-Associated Virus

Structural Proteins

Vaccine Development

Cancer Treatment

Immunogenicity

Recombinant Vector

Papillomavirus

c-Src Inhibitors

Scleroprotein

Tumor Cells

Fusion Proteins

Leukaemia

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10822378 - Mutated structural protein of a parvovirus (2020-11-03),

2. 10408834 - Mutated parvovirus structural proteins as vaccines (2019-09-10),

3. 9624274 - Mutated structural protein of a parvovirus (2017-04-18),

4. 8268837 - Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia (2012-09-18),

5. 8119649 - Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia (2012-02-21),

6. 7968340 - Structural protein of adeno-associated virus with modified antigenicity, its production and its use (2011-06-28),

7. 7556965 - Structural protein of adeno-associated virus with modified antigenicity, its production and its use (2009-07-07),

8. 7494658 - Papilloma virus truncated L1 protein and fusion protein constructs (2009-02-24),

9. 7314912 - AAv scleroprotein, production and use thereof (2008-01-01),

10. 7285381 - Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same (2007-10-23),

11. 7252997 - Structural protein of adeno-associated virus with modified antigenicity, its production and its use (2007-08-07),

12. 7182947 - Papillomavirus truncated L1 protein and fusion protein constructs (2007-02-27),

13. 7078478 - Inhibition of the proliferation of cells of the multiple myeloma (2006-07-18),

14. 7001765 - Adeno-associated virus vector for boosting immunogenicity of cells (2006-02-21),

15. 6926897 - Medicament for the avoidance or treatment of papillomavirus-specific tumour (2005-08-09),

Title: The Innovative Journey of Michael Hallek

Introduction: Michael Hallek, a pioneering inventor hailing from Schondorf, Germany, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Michael Hallek's latest patents focus on advancements in renewable energy technologies, particularly in the development of solar panel efficiency and energy storage solutions.

Career Highlights: With a career spanning over two decades, Michael Hallek has established himself as a leading figure in the tech industry. His innovative spirit and dedication to pushing the boundaries of technology have led to numerous successful inventions and patents.

Collaborations: Throughout his career, Michael Hallek has collaborated with top research institutions and leading tech companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Michael Hallek's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors. His contributions to the field of technology have left an indelible mark, shaping the future of renewable energy and beyond.

Profile summary based on public USPTO records.